Evaluation of effectiveness and safety of hydroxyethyl starch (HES 130 kDa/0.4) in burn resuscitation

Evaluation of effectiveness and safety of hydroxyethyl starch (HES 130 kDa/0.4) in burn resuscitation

Bibliographic Details
Main Authors:	Mokline, A, Rahmani, I, Gharsallah, L, Oueslati, H, Gasri, B, Harzallah, I, Ksontini, A, Messadi, A
Format:	Online
Language:	English
Published:	BioMed Central 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363670/

Similar Items

Relative adrenal insufficiency in burns
by: Mokline, A, et al.
Published: (2013)

Lactate in burn patients: biomarker of sepsis and mortality
by: Mokline, A, et al.
Published: (2012)

Intraabdominal hypertension in burn patients
by: Mokline, A, et al.
Published: (2015)

Is hydroxyethyl starch 130/0.4 safe?
by: Haase, Nicolai, et al.
Published: (2012)

Large-dose hydroxyethyl starch (HES) 130/0.4 in elective coronary artery bypass surgery
by: Kasper, SM, et al.
Published: (2002)

Hydroxyethyl starch HES 130/0.4 in paediatric surgery: results of an explorative, controlled, multicentre safety study
by: Lochbühler, H, et al.
Published: (2003)

In vivo effect of hydroxyethyl starch solution (HES 130/0.4) on different fibrinogen assays
by: Schött, U, et al.
Published: (2014)

Adverse effects of hydroxyethyl starch (HES 130/0.4) on intestinal barrier integrity and metabolic function are abrogated by supplementation with Albumin
by: Wong, Yuk Lung, et al.
Published: (2016)

Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double-blind clinical trial
by: Béchir, Markus, et al.
Published: (2013)

The impact of 30 ml/kg hydroxyethyl starch 130/0.4 vs hydroxyethyl starch 130/0.42 on coagulation in patients undergoing abdominal surgery
by: Staikou, Chryssoula, et al.
Published: (2012)

Resuscitation with hydroxyethyl starch 130/0.4 attenuates intestinal injury in a rabbit model of sepsis
by: Lu, Wei-Hua, et al.
Published: (2015)

Assessment of coagulation with 6% hydroxyethyl starch 130/0.4 in cesarean section
by: Oh, Chung-Sik, et al.
Published: (2012)

Persistent pruritus after hydroxyethyl starch (HES) infusions in critically ill patients
by: Sharland, C, et al.
Published: (1999)

6% Hydroxyethyl starch (HES 130/0.4) diminishes glycocalyx degradation and decreases vascular permeability during systemic and pulmonary inflammation in mice
by: Andreas Margraf, et al.
Published: (2018-05-01)

The Evaluation of Hydroxyethyl Starch (6% HES 130/0.4) Solution’s Potential Preventive Effects on Coagulation Status in Women with Gynecologic Malignancies Using Rotation Thromboelastography
by: Akay, Meltem Olga, et al.
Published: (2014)

Markers of endothelial dysfunction in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs. ringer's acetate
by: Müller, RB, et al.
Published: (2015)

Reporting bias in trials of volume resuscitation with hydroxyethyl starch
by: Wiedermann, Christian J.
Published: (2014)

Comparison of 6% HES 130/0.4 in a balanced electrolyte solution versus 6% HES 130/0.4 in saline solution in cardiac surgery
by: Base, E, et al.
Published: (2006)

Large volume resuscitation with hydroxyethyl starch (HES) in lactated Ringer's (LR) solution restores perfusion, minimally induces hyperchloremia or impairs coagulation
by: Kaplan, LJ, et al.
Published: (2001)

HES 130/0.4, a new HES specification: tissue storage after multiple infusions in rats
by: Bepperling, F, et al.
Published: (1999)

HES 130/0.4, a new HES specification: pharmacokinetics after multiple infusions of 10% solutions in healthy volunteers
by: Bepperling, F, et al.
Published: (1999)

Hydroxyethyl starch 200/0.5 induces more renal macrophage infiltration than hydroxyethyl starch 130/0.42 in an isolated renal perfusion model
by: Hüter, L, et al.
Published: (2008)

Blood substitutes consumption and coagulation changes: 200/0.5 vs 130/0.4 hydroxyethyl starch administration
by: Costa, MG, et al.
Published: (2003)

Hydroxyethyl starch 130/0.4 and sodium chloride injection as adjunctive therapy in patients with cerebral hypoperfusion
by: Han, Junliang, et al.
Published: (2012)

Effect of 6% Hydroxyethyl Starch 130/0.4 as a Priming Solution on Coagulation and Inflammation Following Complex Heart Surgery
by: Cho, Jang-Eun, et al.
Published: (2014)

Hydroxyethyl starch 130/0.4 or hypertonic saline solution to decrease inflammatory response in hemorrhagic shock?
by: Esnault, Pierre, et al.
Published: (2013)

Interactions between the volume effects of hydroxyethyl starch 130/0.4 and Ringer´s acetate
by: Hahn, Robert G, et al.
Published: (2013)

Correction: Hydroxyethyl Starch (HES 130/0.4) Impairs Intestinal Barrier Integrity and Metabolic Function: Findings from a Mouse Model of the Isolated Perfused Small Intestine
Published: (2015)

Hydroxyethyl Starch (HES 130/0.4) Impairs Intestinal Barrier Integrity and Metabolic Function: Findings from a Mouse Model of the Isolated Perfused Small Intestine
by: Wong, Yuk Lung, et al.
Published: (2015)

Concerns about renal safety of HES 130
by: Wiedermann, Christian J, et al.
Published: (2013)

Conjugates of methylated cyclodextrin derivatives and hydroxyethyl starch (HES): Synthesis, cytotoxicity and inclusion of anaesthetic actives
by: Markenstein, Lisa, et al.
Published: (2014)

Effects of synthetic colloids on oxidative stress and inflammatory response in hemorrhagic shock: comparison of hydroxyethyl starch 130/0.4, hydroxyethyl starch 200/0.5, and succinylated gelatin
by: Chen, Gan, et al.
Published: (2013)

Hydroxyethyl starch in severe sepsis: end of starch era?
by: Estrada, Carlos A, et al.
Published: (2013)

In vitro effects of 6 % hydroxyethyl starch 130/0.42 solution on feline whole blood coagulation measured by rotational thromboelastometry
by: Albrecht, Nathalie A., et al.
Published: (2016)

Advantages of 6% hydroxyethyl starch 130/0.4 (Voluven®) at repetitive high dose levels in patients with severe cranio-cerebral trauma
by: Neff, ThA, et al.
Published: (2001)

Efficacy and safety of 10% HES 130/0.4 versus 10% HES 200/0.5 for plasma volume expansion in cardiac surgery patients
by: Ertmer, C, et al.
Published: (2011)

Volume substitution therapy with HES 130/0.4 (Voluven®) versus HES 450/0.7 (hetastarch) during major orthopedic surgery
by: Gandhi, S, et al.
Published: (2005)

Effects of Acute Bleeding Followed by Hydroxyethyl Starch 130/0.4 or a Crystalloid on Propofol Concentrations, Cerebral Oxygenation, and Electroencephalographic and Haemodynamic Variables in Pigs
by: Silva, Aura, et al.
Published: (2014)

Effect of 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride (Voluven®) on complications after subarachnoid hemorrhage: a retrospective analysis
by: Khan, Shariq A, et al.
Published: (2013)

Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement is safe and effective in children
by: Suempelmann, R, et al.
Published: (2008)